We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy.
- Authors
Zheng, Hongyu; Peng, Xueqiang; Yang, Shuo; Li, Xinyu; Huang, Mingyao; Wei, Shibo; Zhang, Sheng; He, Guangpeng; Liu, Jiaxing; Fan, Qing; Yang, Liang; Li, Hangyu
- Abstract
Hepatocellular carcinoma (HCC), one of the most malignant tumors, is characterized by its stubborn immunosuppressive microenvironment. As one of the main members of the tumor microenvironment (TME) of HCC, tumor-associated macrophages (TAMs) play a critical role in its occurrence and development, including stimulating angiogenesis, enhancing immunosuppression, and promoting the drug resistance and cancer metastasis. This review describes the origin as well as phenotypic heterogeneity of TAMs and their potential effects on the occurrence and development of HCC and also discusses about various adjuvant therapy based strategies that can be used for targeting TAMs. In addition, we have highlighted different treatment modalities for TAMs based on immunotherapy, including small molecular inhibitors, immune checkpoint inhibitors, antibodies, tumor vaccines, adoptive cellular immunotherapy, and nanocarriers for drug delivery, to explore novel combination therapies and provide feasible therapeutic options for clinically improving the prognosis and quality of life of HCC patients.
- Subjects
HEPATOCELLULAR carcinoma; DRUG resistance in cancer cells; IMMUNE checkpoint inhibitors; BIOLOGY; IMMUNOTHERAPY; NANOMEDICINE
- Publication
Cell Death Discovery, 2023, Vol 9, Issue 1, p1
- ISSN
2058-7716
- Publication type
Article
- DOI
10.1038/s41420-023-01356-7